Skip to main content

TYVASO and TYVASO DPI are approved for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve the ability to exercise.

SELECT A CONDITION
Skip to main content
Hamburger button
Close button
SELECT A CONDITION

TAKING ACTION

Taking action now may help you be more active with family and friends

Be ready to ask about checking for PH.

Because PH can appear at any time, it’s up to you to:

  • Ask your doctor about using your current ILD tests to check for PH
  • Tell your doctor about any new or worsening symptoms
  • Understand that if clinical signs/symptoms and routine tests indicate PH, but the echo shows no PH, your doctor may need to take an additional step to rule out PH

Be vigilant about having your doctor check for PH at every appointment, as PH can appear at any time.

A delay in detecting PH can impact your health, so get started at your very next appointment.

1 2 3 4 5 6 7 Complete

Ready to talk to your doctor about PH?

Coach Phil

Answer a few quick questions about your symptoms, recent tests, and conversations with your doctor.

At the end, you can download a personalized guide that includes a summary of your answers and suggested questions to help you discuss PH with your doctor at your next appointment.

Create your personalized guide

If you have been diagnosed with interstitial lung disease (ILD), this personalized guide is designed to help you prepare for a more informed conversation at your next appointment. These questions are not intended to screen or diagnose pulmonary hypertension (PH) but rather to gather information to discuss with your doctor.

Your guide will help you

  • Share the symptoms or changes you may be experiencing
  • Review any recent tests with your doctor
  • Ask questions that make sure PH is considered in your care

Since your last doctor's visit, have any of these symptoms gotten worse?

Select all that apply

Have you experienced any of the following additional symptoms since your last doctor's visit?

Select all that apply

Have you had any of the following tests in the past year?

Select all that apply

BNP=B-type natriuretic peptide; NT-proBNP=N-terminal pro-B-type natriuretic peptide.

As you may know, interstitial lung disease (ILD) is a group of serious, progressive lung disorders that can damage the lungs and make it harder to breathe. Do you know what type of ILD you have?

Have you ever talked with your doctor about pulmonary hypertension (PH)?

Have you ever been tested for PH?

Sign up to download your personalized guide

Based on your answers, a customized guide has been created for you to take to your next doctor's appointment.

Sign up below to access your guide.

*Indicates required fields

Your personalized discussion guide is ready

Here's your guide to take to your next doctor's appointment.

Reminder: Having interstitial lung disease (ILD) puts you at higher risk of pulmonary hypertension (PH) and can make it hard to recognize, but you can make a difference in detecting PH early. Take charge of your health and use this guide to start or continue the conversation with your doctor.

There is treatment available that can help with PH-ILD.

LEARN MORE
Please make a selection to continue.

Myth Buster 1

Checking for PH-ILD: Separating fact from fiction.

VIEW NOW

Myth Buster 2

Echocardiogram: Separating fact from fiction.

VIEW NOW

KEEP LEARNING TO HELP GET ALL YOU CAN OUT OF EVERY DAY

Sign up for the Raise The Questions program with Coach Phil

No matter where you are in your lung health journey, Coach Phil will help you know the specific questions to ask and the information you need to raise your chance be more active with your family and friends.

Join Now

Learn more about treating PH-ILD.

DISCOVER TYVASO

Find resources for people with PH-ILD.

GET SUPPORT

IMPORTANT SAFETY
INFORMATION

Before you take TYVASO or TYVASO DPI, tell your healthcare provider about all of your medical conditions, including if you:

  • Have low blood pressure
  • Have or have had bleeding problems
EXPAND

IMPORTANT SAFETY
INFORMATION

COLLAPSE

Before you take TYVASO or TYVASO DPI, tell your healthcare provider about all of your medical conditions, including if you:

  • Have low blood pressure
  • Have or have had bleeding problems
  • Have asthma or chronic obstructive pulmonary disease (COPD)
  • Are pregnant or plan to become pregnant. It is not known if either product will harm your unborn baby.
  • Are breastfeeding or plan to breastfeed. It is not known if either product passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Either product and other medicines may affect each other.

Especially tell your healthcare provider if you take:

  • Medicines used to treat high blood pressure or heart disease
  • Medicines that decrease blood clotting (anticoagulants)
  • Water pills (diuretics)
  • Gemfibrozil (Lopid®) or rifampin (Rimactane®, Rifadin®, Rifamate®, Rifater®)

What are the possible side effects of TYVASO or TYVASO DPI?

Both products can cause serious side effects, including:

  • Low blood pressure (symptomatic hypotension). If you have low blood pressure, either product may lower your blood pressure more.
  • Bleeding problems. Either product may increase the risk of bleeding, especially in people who take blood thinners (anticoagulants).

The most common side effects of both products are cough, headache, throat irritation and pain, nausea, reddening of the face and neck (flushing), fainting or loss of consciousness, dizziness, diarrhea, and shortness of breath. Like other inhaled prostaglandins, you may have trouble breathing after taking TYVASO or TYVASO DPI because it may cause the muscles around your airway to tighten (bronchospasm). These are not all the possible side effects. Call your doctor for medical advice about side effects or if you have trouble breathing.

You may report side effects to the FDA at 

You are now leaving the Tyvaso.com website

This link will take you to a site maintained by a third party who is solely responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return to www.TYVASO.com.

CONTINUE
www.fda.gov/MedWatch

or call 1-800-FDA-1088.

What are TYVASO and TYVASO DPI?

TYVASO (treprostinil) Inhalation Solution and TYVASO DPI (treprostinil) Inhalation Powder are prescription medicines used in adults to treat:

  • Pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. TYVASO or TYVASO DPI can improve the ability to exercise. Your ability to exercise decreases 4 hours after taking TYVASO or TYVASO DPI. It is not known if TYVASO or TYVASO DPI is safe and effective in children under 18 years of age.
  • Pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3), which is high blood pressure in the lungs due to inflammation and sometimes scarring in the lungs. TYVASO or TYVASO DPI can improve the ability to exercise.

The risk information provided here is not comprehensive. To learn more about TYVASO or TYVASO DPI, talk with your healthcare provider. Please see Full Prescribing Information for TYVASO or TYVASO DPI, Instructions for Use manuals for TD-100 and TD-300 TYVASO® Inhalation System and TYVASO DPI® Inhalation Powder, and additional information at www.TYVASO.com or call 1-844-UNITHER (1-844-864-8437).


TYVISIconSEP2024

BNP=B-type natriuretic peptide; DLCO=diffusing capacity of the lung for carbon monoxide; ILD=interstitial lung disease; NT-proBNP=N-terminal pro–B-type natriuretic peptide; PH=pulmonary hypertension.